Intelligent Bio Solutions Income Statement (2019-2025) | INBS

Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Revenue & cost
Revenue (Quarter)
0.06M0.28M0.03M0.42M0.18M0.19M1.19M0.35M0.36M0.46M0.44M0.80M0.76M0.82M0.87M0.61M0.73M
Cost of Revenue (Quarter)
0.11M0.42M0.39M0.56M0.56M0.65M0.53M0.38M0.39M
Gross Profit (Quarter)
0.24M0.03M0.05M0.23M0.20M0.18M0.35M0.22M0.34M
Operating items
Depreciation & Amortization - Total (Quarter)
0.01M0.02M
Research & Development (Quarter)
0.03M0.34M0.50M1.31M0.11M2.64M0.41M0.69M0.08M0.00M0.30M0.13M0.10M0.35M0.47M0.75M0.95M0.51M0.36M0.58M
Selling, General & Administrative (Quarter)
0.52M0.67M1.01M1.15M1.33M1.00M1.12M1.46M1.45M2.25M1.90M2.43M2.46M1.71M2.43M1.95M1.81M2.41M
Restructuring Costs (Quarter)
0.03M
Other Operating Expenses (Quarter)
0.17M0.19M1.66M524.00-1.34M-2.08M-1.21M-0.42M-6.34M-2.66M0.31M0.29M0.32M0.30M0.31M0.30M
Operating Expenses (Quarter)
0.72M1.20M3.17M2.46M1.44M3.64M1.54M2.15M1.53M2.64M6.69M2.79M2.87M2.34M3.22M0.75M3.20M2.62M3.07M0.58M
Operating Income (Quarter)
-0.66M-0.92M-3.14M-0.85M-1.44M-3.47M-1.34M-2.09M-1.22M-2.13M-6.54M-2.70M-2.53M-1.99M-2.95M-2.81M-2.73M-2.26M-2.56M
EBIT (Quarter)
-0.66M-0.92M-3.14M-0.85M-1.44M-3.47M-1.34M-2.09M-1.22M-2.13M-6.54M-2.70M-2.53M-1.99M-2.95M-2.81M-2.73M-2.26M-2.56M
Non-operating items
Non Operating Investment Income (Quarter)
-0.14M
Interest & Investment Income (Quarter)
70.00434.000.01M0.01M0.00M0.00M0.00M0.00M0.01M0.00M508.0089.00139.000.00M0.01M0.05M0.02M0.02M
Other Non Operating Income (Quarter)
-0.19M-0.09M0.01M-892.00-0.00M14.0010.00-893.00-0.00M-0.01M0.01M-893.00-555.00-996.00-51.00-750.000.01M
Non Operating Income (Quarter)
-0.41M-1.07M-0.00M0.00M0.00M0.00M-0.00M-87.000.00M1.70M0.19M0.03M0.09M0.01M-0.03M0.02M0.03M0.01M0.01M
Net income details
EBT (Quarter)
-1.08M-1.99M-3.14M-0.85M-1.44M-3.46M-1.34M-2.08M-1.21M-2.13M-6.35M-2.70M-2.56M-2.02M-2.99M-2.81M-2.69M-2.26M-2.55M
Profit After Tax (Quarter)
-1.08M-1.99M-3.13M-0.85M-1.44M-3.46M-1.34M-2.11M-1.21M-0.43M-6.35M-2.67M-2.43M-1.98M-2.98M-2.82M-2.69M-2.26M-2.55M
Equity Income (Quarter)
1.79M0.27M0.09M0.13M0.04M
Income from Non-Controlling Interests (Quarter)
-0.00M-0.01M-0.01M0.00M-0.01M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Income from Continuing Operations (Quarter)
-1.08M-1.99M-3.14M-0.85M-1.44M-3.46M-1.34M-2.08M-1.21M-2.13M-6.35M-2.70M-2.56M-2.02M-2.99M-2.81M-2.69M-2.26M-2.55M
Consolidated Net Income (Quarter)
-1.08M-1.99M-3.14M-0.85M-1.44M-3.46M-1.34M-2.08M-1.21M-2.13M-6.35M-2.70M-2.56M-2.02M-2.99M-2.81M-2.69M-2.26M-2.55M
Income towards Parent Company (Quarter)
-1.08M-1.99M-3.14M-0.85M-1.44M-3.46M-1.34M-2.08M-1.21M-2.13M-6.35M-2.70M-2.56M-2.02M-2.99M-2.81M-2.69M-2.26M-2.55M
Net Income towards Common Stockholders (Quarter)
-1.08M-1.99M-3.14M-0.85M-1.44M-3.46M-1.34M-2.08M-1.21M-2.13M-6.35M-2.70M-2.56M-2.02M-2.99M-2.81M-2.69M-2.26M-2.55M
Additional items
EPS (Basic) (Quarter)
-0.12-0.23-0.27-12.87-0.10-4.65-1.79-2.79-1.62-5.56-68.67-22.96-12.48-2.07-1.430.26-0.70-4.96-4.4113.92
EPS (Weighted Average and Diluted) (Quarter)
-2.84-1.63-5.56-68.67-22.96-12.48-2.07-1.430.26-0.70-4.96-4.4113.92
Shares Outstanding (Weighted Average) (Quarter)
8.63M8.62M11.80M0.52M14.01M0.74M0.73M0.73M14.89M0.08M0.08M0.08M0.19M0.95M1.11M1.59M3.81M0.42M0.47M5.51M
Shares Outstanding (Diluted Average) (Quarter)
0.73M0.74M0.07M0.08M0.08M0.19M0.95M1.11M1.59M3.81M0.42M0.47M5.27M
EBITDA (Quarter)
-1.12M-1.95M-3.40M-0.87M-1.50M-3.45M-1.33M-2.16M-1.35M-0.06M-6.42M-2.61M-2.44M-1.90M-3.13M-2.81M-2.48M-2.40M-2.43M
Interest Expenses (Quarter)
0.04M0.03M0.04M0.02M0.01M0.01M